In patients with type 2 diabetes mellitus and prediabetes, most studies have observed lower circulating irisin levels than controls [17–20], suggesting a downregulated level of irisin under the conditions of impaired glucose tolerance [6]. This evidence concerns the gene FNDC5 and prediabetes syndrome.